Replies to post #589 on BiondVax Pharmaceuticals Ltd (BVXV)

[midastouch017]

Dr. Ron Babecoff commented: “I feel it is the right time to hand over leadership of the Company to Amir, who I believe has the right personality and experience to lead BiondVax to its next phase.”
Mr. Amir Reichman said: “I am extremely excited and thrilled to assume the role of BiondVax's CEO,” and added, “while results of the M-001 vaccine candidate's Phase 3 trial were disappointing, our team has gained many strengths and experience in innovative product research, preclinical and clinical development, and GMP manufacturing in our state-of-the-art facility in Jerusalem.”

Time will tell what next phase means!